WebThe most downloaded articles from Progress in Cardiovascular Diseases in the last 90 days. Debunking the vegan myth: The case for a plant-forward omnivorous whole-foods diet. … WebFeb 27, 2024 · Whereas extensive clinical and statistical studies have identified major and contributing factors that increase the risk of cardiovascular disease, including— (1) high blood pressure; (2) high blood cholesterol; (3) smoking tobacco products; (4) exposure to tobacco smoke; (5) physical inactivity; (6) obesity; and (7) diabetes mellitus;
Subscribe to Progress in Cardiovascular Diseases - 0033-0620
WebThe metabolic syndrome (MetS), first introduced by Haller in 1975, was sometimes also known as insulin resistance syndrome, syndrome X, and plurimetabolic syndrome. In … WebApr 11, 2024 · A planned interim analysis of data from the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) study found that participants who took pitavastatin calcium, a daily statin, lowered their risk of major adverse cardiovascular events by 35% compared with those receiving a placebo. our community bridge
Daily statin medication could improve cardiovascular outcomes in …
WebMay 27, 2024 · Progress in Cardiovascular Diseases IS is increased by a factor of 2.71 and approximate percentage change is 46.17% when compared to preceding year 2024, which … WebApr 11, 2024 · Purpose of Review To review the benefits, challenges, and advances in cardiac rehabilitation (CR) in the management of cardiovascular disease (CVD). Recent Findings Novel strategies of delivering CR are being studied that use remote technologies to link patients with CR professionals. These strategies used alone or in tandem with center … Web1 day ago · The NIH stopped a clinical trial early after finding that daily statin medication, pitavastatin calcium, reduced cardiovascular disease risk in people living with HIV by 35%. The findings could lead to improved cardiovascular outcomes for this population using common cholesterol-lowering medicines. our community activities eyfs